Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 68-year-old man presents to the clinic with severe pain, swelling, and redness in his right knee that began abruptly 18 hours ago. He has a history of poorly controlled type 2 diabetes mellitus, diabetic nephropathy, and hypertension. His current medications include insulin glargine, insulin lispro, and amlodipine. Vital signs show a temperature of 37.3°C (99.1°F), blood pressure of 145/88 mmHg, and heart rate of 88/min. Physical examination reveals an erythematous, markedly swollen, and exquisitely tender right knee with severely limited range of motion.

Laboratory studies reveal:
- Serum creatinine: 2.7 mg/dL (baseline 2.5 mg/dL)
- Estimated GFR: 24 mL/min/1.73 m²
- Serum glucose: 345 mg/dL
- Hemoglobin A1c: 10.4%

Arthrocentesis of the right knee yields 4 mL of turbid yellow fluid. Synovial fluid analysis shows a leukocyte count of 22,000/mm³ with 85% neutrophils. Polarized light microscopy demonstrates numerous needle-shaped, negatively birefringent crystals. Gram stain of the fluid shows no organisms.

Which of the following is the most appropriate pharmacologic intervention for this patient's acute joint condition?

  1. A
    Oral indomethacin
  2. B
    Oral colchicine
  3. Intra-articular triamcinoloneCevap
  4. D
    Oral prednisone
  5. E
    Intravenous ceftriaxone

Cevap

Intra-articular triamcinolone
Intra-articular triamcinolone is the most appropriate next step in management for this patient. The treatment of an acute gout flare typically involves NSAIDs, colchicine, or systemic corticosteroids. However, the choice of agent is heavily dictated by patient comorbidities. This patient has advanced chronic kidney disease (stage 4) and severely uncontrolled diabetes. A localized intra-articular corticosteroid injection provides excellent anti-inflammatory relief for a single affected joint without causing the systemic side effects that would compromise his renal or metabolic status.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical presentation and synovial fluid analysis.
The patient has an acute gout flare, confirmed by the presence of numerous needle-shaped, negatively birefringent crystals.
Accurate diagnosis is required before selecting targeted pharmacologic therapy.
2
Evaluate the patient's baseline comorbidities and current metabolic state.
The patient has advanced chronic kidney disease (eGFR 24 mL/min/1.73 m²) and severe, poorly controlled diabetes mellitus (glucose 345 mg/dL, HbA1c 10.4%).
Comorbidities significantly restrict the available therapeutic options for acute gout.
3
Screen standard first-line gout therapies for contraindications against the identified comorbidities.
NSAIDs and colchicine are contraindicated due to advanced CKD. Systemic corticosteroids are highly unfavorable due to uncontrolled severe hyperglycemia.
Administering standard systemic agents would cause significant iatrogenic harm, such as acute renal failure or a hyperglycemic crisis.
4
Select the most appropriate alternative intervention.
Intra-articular triamcinolone is chosen as the safest and most effective targeted therapy.
A localized injection treats the monoarticular flare effectively without producing the harmful systemic effects associated with oral agents.

Anahtar Kavram

In patients with acute monoarticular gout who have multiple systemic contraindications (such as advanced CKD precluding NSAIDs/colchicine, and uncontrolled diabetes precluding systemic steroids), intra-articular corticosteroid injection is the treatment of choice.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru